Reproducibility of proton magnetic resonance spectroscopy imaging measurements of normal human hippocampus at 1.5 T: Clinical implications

Journal of Neuroimaging

Volumn 11, Issue 2, 2001, Pages 194-201

  Maton, B ^a   Londono, A ^a   Sawrie, S ^a   Knowlton, R ^a   DenHollander, J ^b   Kuzniecky, R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Brain; Hippocampus; N acetylaspartate; Proton magnetic resonance spectroscopy; Reproducibility

Indexed keywords

ACETIC ACID; CHOLINE; CREATINE; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NORMAL HUMAN; PHANTOM; PROTON NUCLEAR MAGNETIC RESONANCE; RELIABILITY; REPRODUCIBILITY; VOLUNTEER;

EID: 0035718239     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2001.tb00033.x     Document Type: Article

References (32)

1. Imaging and epilepsy
2. Serial precision of metabolic peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain
3. In vivo proton magnetic resonance spectroscopy of human brain
4. Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain
5. 1HMRS of brain
6. 1HMRS of the human brain in vivo based on the stimulation phantom calibration strategy
7. Image selected in vivo spectroscopy: A new technique for spatially selective NMR spectroscopy
8. 1H-MRS in vivo
9. 1H-MRS study of probable Alzheimer's disease and normal aging: Implications for longitudinal monitoring of demential progression
10. Letter to the editor
11. Oblique proton chemical shift imaging for the presurgical localization of mesial temporal lobe epilepsy
12. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging
13. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer's disease
14. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging
15. Proton MR spectroscopy in patients with seizure disorders
16. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images
17. Magnetic resonance spectroscopy in temporal lobe epilepsy
18. Temporal lobe epilepsy: Presurgical localization with proton chemical shift imaging
19. Contralateral metabolic recovery following temporal lobectomy
20. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: Evidence from proton MR spectroscopic imaging
21. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET
22. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: A series of 100 patients
23. A method of assessing change in a single subject: An alteration of the RC index
24. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research
25. Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery
26. MRI-PET registration with automated algorithm
27. Functional MR imaging correlations with positron emission tomography
28. 1H-MRSI follow-up studies on epilepsy show strongly altered metabolite concentrations after surgery
29. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H MRSI
30. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures